Exclusive Chair Interview with Justin Mason-Home ahead of SMi's 5th Annual Highly Potent API

LONDON - Amzeal -- SMi Group had the opportunity to catch up with the Chair of the conference, Justin Mason-Home, Director, HPAPI Project Services Limited, where he provided his thoughts on the development of the HPAPI market, the importance of the 2021 conference and discusses APi issues and challenges.

This is a thrilling insight into what is in store for Highly Potent Active Pharmaceutical Ingredients Conference 2021, convening virtually on the 10th – 11th May.

Interested parties can attend the conference at only £299 for pharmaceutical and biotechnology companies and £699 for vendors and commercial firms, visit http://www.highlypotentapi.com/pr2

More on Amzeal News

• Concerned Citizens of South Central Los Angeles Send Open Letter To Biden Administration
• Footprint Project Partners with Clean Energy Leaders to Deploy Solar Energy Storage to Texas for Winter Storm Recovery
• Sandline Global Fortifies World-Class Executive Team: Glenn Hopper Joins as Chief Financial Officer
• RSTOR Enhances Software Defined Cloud Platform to Support Hybrid, Multi-Cloud Enterprise Infrastructures
• GBKSOFT reveals the benefits of Building Websites with PHP in 2021?

Justin will be chairing the two-day conference on 10 and 11 May 2021 as a virtual live event and he will be speaking on day one with an opening keynote on PPE in Covid-19 vs Engineering Controls in Pharma

Giving an insight into HPAPi 2021 is an excerpt from the exclusive Chair interview:

The Highly Potent API industry has continued to develop further in recent years, what key developments have you witnessed in this time?
'What many people describe as 'HPAPI' should, in many cases, really be described as potent APIs.  Overall, what one has to do with HPAPIs is what one always had to do - understand the [toxicological] hazard, undertake robust risk assessments and put in place controls that are protective of both product and workers.  If I was pushed to point out what key developments have taken place, it would be the establishment of health-based exposure limits (HBELs), a much more scientific approach compared to what preceded it and the rise of the use of flexible containment as a means for protecting both processes and workers.'

More on Amzeal News

• Syxsense Announces Integration with Microsoft Office 365
• Launch of Trace One E-Sourcing Will Boost Retailers' Private Label Speed to Market
• Australian Content Farm Kantado gets its first US hit single
• New Video Streaming Startup, Relax Scenes, Launches Indiegogo Campaign to Support Their Expansion
• Bronx DWI Lawyer Announces New Website

The full agenda, speaker line-up, brochure and rest of the interview can be viewed online at: http://www.highlypotentapi.com/pr2

This event is sponsored by: Catalent Pharma Solutions & FPS Food and Pharma Systems.
To join the conference as a sponsor and exhibitor, please get in touch with Alia Malick, Director on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

SMi's 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference
10th – 11th May 2021
Virtual Conference: Online Access Only
http://www.highlypotentapi.com/pr2
#SMiHPAPi